Craft

Penumbra

Stock Price

$227.8

2023-12-01

Market Capitalization

$8.8 B

2023-12-01

Revenue

$847.1 M

FY, 2022

Penumbra Summary

Company Summary

Overview
Penumbra designs, develops, manufactures, and markets medical devices. The Company offers neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies, aspiration based thrombectomy systems and accessory devices, and revascularization device for mechanical thrombectomy. It also provides neurovascular embolization coiling systems and neurovascular stents. In addition, the Company offers neurosurgical aspiration tools and detachable embolic coil systems and microcatheter devices.
Type
Public
Status
Active
Founded
2004
HQ
Alameda, CA, US | view all locations
Website
http://penumbrainc.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Arani Bose, Chief Innovator and Director

    • Don Kassing
    • Thomas C. Wilder

      Thomas C. Wilder, Director

      LocationsView all

      13 locations detected

      • Alameda, CA HQ

        United States

        1321 Harbor Bay Pkwy

      • Alameda, CA

        United States

        1351 Harbor Bay Pkwy

      • Atlanta, GA

        United States

        Atlanta, GA, USA

      • Chicago, IL

        United States

        Chicago, IL, USA

      • Livermore, CA

        United States

        6262 Patterson Pass Rd suite a

      • Melbourne, FL

        United States

        Melbourne, FL, USA

      and 7 others

      Penumbra Financials

      Summary Financials

      Revenue (Q3, 2023)
      $270.9M
      Gross profit (Q3, 2023)
      $177.7M
      Net income (Q3, 2023)
      $9.2M
      Cash (Q3, 2023)
      $100.8M
      EBIT (Q3, 2023)
      $12.6M
      Enterprise value
      $8.7B

      Footer menu